Senores Pharmaceuticals Profit & Loss Annual

BSE: - | NSE: - | ISIN: - | Sector: -
820.20 +16.05 (2.00%)Updated : 10 Apr 2026
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Total Operating Expense 325.39182.9224.2912.92
Other Net 7.491.750.260.46
Diluted Weighted Average Shares 3.643.333.333.33
Gain( Loss)on Saleof Assets 0.00-0.03-0.16-
Depreciation/ Amortization 16.8410.021.780.71
Operating Income 72.8631.6111.051.25
Net Income 58.5631.468.430.99
Income Availableto Com Excl Extra Ord 58.5631.468.430.99
Other Operating Expenses Total 39.1021.724.501.24
Net Income Before Taxes 70.5724.9412.441.14
Minority Interest 0.22-1.25--
Net Income After Taxes 58.3432.718.430.99
Income Availableto Com Incl Extra Ord 58.5631.468.430.99
Costof Revenue Total 195.98111.5712.778.03
Gross Profit 202.27102.9622.576.14
Interest Inc( Exp) Net- Non- Op Total -9.78-8.381.28-0.57
Diluted Net Income 58.5631.468.430.99
Provisionfor Income Taxes 12.23-7.764.000.15
period Type ----
Net Income Before Extra Items 58.5631.468.430.99
Total Revenue 398.25214.5235.3414.17
period Length 12.0012.0012.0012.00
Revenue 398.25214.5235.3414.17
Selling/ General/ Admin Expenses Total 72.9839.625.242.95
Diluted Normalized EPS 16.109.462.570.30
Research Development 0.49---
Diluted EPS Excluding Extra Ord Items 16.109.462.540.30
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,414.00+23.00(1.65%)
801.40-42.95 (-5.09%)
979.80-40.25 (-3.95%)